PRECISION ONCOLOGY MUST MEET SURGICAL ONCOLOGY
Downloads
Download data is not yet available.
References
1. 2015 State of The Union Address by President Barack Obama 2015.
2. Konstantinidou MK, Karaglani M, Panagopoulou M, Fiska A, Chatzaki E. Are the Origins of Precision Medicine Found in the Corpus Hippocraticum. Mol Diagn Ther. 2017;21:601-606.
3. Malone ER, Oliva M, Sabatini PJB, Stockley TL, Siu LL. Molecular profiling for precision cancer therapies. Genome Med. 2020;12:8.
4. Collins FS, Varmus H. A new initiative on precision medicine. New England journal of medicine. 2015
5. Garraway LA. Genomics-driven oncology: framework for an emerging paradigm. J Clin Oncol. 2013;31:1806-1814.
6. National RCUSCOAFFDANTOD. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. 2011
7. Janiaud P, Serghiou S, Ioannidis JPA. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology. Cancer Treat Rev. 2019;73:20-30.
8. Tsimberidou AM, Fountzilas E, Nikanjam M, Kurzrock R. Review of precision cancer medicine: Evolution of the treatment paradigm. Cancer Treat Rev. 2020;86:102019.
9. Yan L, Zhang W. Precision medicine becomes reality-tumor type-agnostic therapy. Cancer Commun (Lond). 2018;38:6.
10. Oh DY, Bang YJ. HER2-targeted therapies – a role beyond breast cancer. Nat Rev Clin Oncol. 2020;17:33-48.
11. Cady B. Basic principles in surgical oncology. Arch Surg. 1997;132:338-346.
12. editors. Precision in liver surgery. Seminars in liver disease 33(03); 2013; Thieme Medical Publishers; 2013.
2. Konstantinidou MK, Karaglani M, Panagopoulou M, Fiska A, Chatzaki E. Are the Origins of Precision Medicine Found in the Corpus Hippocraticum. Mol Diagn Ther. 2017;21:601-606.
3. Malone ER, Oliva M, Sabatini PJB, Stockley TL, Siu LL. Molecular profiling for precision cancer therapies. Genome Med. 2020;12:8.
4. Collins FS, Varmus H. A new initiative on precision medicine. New England journal of medicine. 2015
5. Garraway LA. Genomics-driven oncology: framework for an emerging paradigm. J Clin Oncol. 2013;31:1806-1814.
6. National RCUSCOAFFDANTOD. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. 2011
7. Janiaud P, Serghiou S, Ioannidis JPA. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology. Cancer Treat Rev. 2019;73:20-30.
8. Tsimberidou AM, Fountzilas E, Nikanjam M, Kurzrock R. Review of precision cancer medicine: Evolution of the treatment paradigm. Cancer Treat Rev. 2020;86:102019.
9. Yan L, Zhang W. Precision medicine becomes reality-tumor type-agnostic therapy. Cancer Commun (Lond). 2018;38:6.
10. Oh DY, Bang YJ. HER2-targeted therapies – a role beyond breast cancer. Nat Rev Clin Oncol. 2020;17:33-48.
11. Cady B. Basic principles in surgical oncology. Arch Surg. 1997;132:338-346.
12. editors. Precision in liver surgery. Seminars in liver disease 33(03); 2013; Thieme Medical Publishers; 2013.
Published
2021-08-09
How to Cite
PEREIRA-LEAL, José B..
PRECISION ONCOLOGY MUST MEET SURGICAL ONCOLOGY.
Revista Portuguesa de Cirurgia, [S.l.], n. 50, p. 19-21, aug. 2021.
ISSN 2183-1165.
Available at: <https://revista.spcir.com/index.php/spcir/article/view/908>. Date accessed: 24 apr. 2024.
Section
Editor's Corner
